Women had a lower probability of receiving any disease-modifying treatment (DMT) and were even less likely to get ...

Sanofi has shared data from the phase 3 HERCULES trial that could rescue its multiple sclerosis (MS) drug candidate ...

Pathways to Cures Roadmap was created by a number of MS representatives and was endorsed by more than 30 organizations.

Among 282 patients with pediatric-onset MS, 39% started high-efficacy therapy early (at ages 12-17), and 61% started late ...

Early, aggressive treatment of brain lesions caused by multiple sclerosis could help ward off faster decline in patients, a ...

MS experts are recommending updates to the 2017 McDonald diagnostic criteria that aim to make diagnosis easier, faster and more accurate.

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

The online program "Eating Well with MS" improved dietary behavior among multiple sclerosis patients and was deemed valuable, ...

New research presented today at ECTRIMS 2024 reveals that initiating monoclonal antibody therapy during childhood, rather than delaying treatment until early adulthood, significantly reduces long-term ...

MtoZ Biolabs provides advanced C-terminal sequencing with LC-MS/MS, offering high sensitivity, specificity, and compliance with ICH Q6B. Services include comprehensive analysis, detailed reports, and ...

A study has revealed significant therapeutic inertia in the treatment of women with multiple sclerosis (MS), highlighting gender disparities that ...

Highly effective MS treatments like monoclonal antibodies and immune-suppressing drugs “may lead to better clinical outcomes ...